Determining biodistribution of pharmaceutical dosage forms
During the clinical study, gamma scintigraphy can be employed using our on-site dedicated dual head gamma camera to evaluate deposition, residence, clearance, and dispersion of pharmaceutical dosage forms in healthy volunteers and patients.
Our approach is tailored to the specific objectives of the study, conducting planar scintigraphy scans to non-invasively assess regional or whole body radiolabel distribution. Analysis of the images enables the deposition, residence, clearance and dispersion of the dosage form to be characterised.
The scintigraphic analysis can also be complemented with expertise in pharmacokinetic and pharmacodynamic evaluations, drug assay development and bioanalysis.